o-Toluoyl Chloride CAS 933-88-0 Tolvaptan Yepakati Fekitori Yepamusoro Hunhu

Tsanangudzo Pfupi

Kemikari Zita: o-Toluoyl Chloride

CAS: 933-88-0

Chiyero: ≥99.0%

Chitarisiko: Colorless Clear Liquid

Pakati peTolvaptan (CAS 150683-30-0) yekurapa kweHyponatremia

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com  


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name o-Toluoyl Chloride
Mashoko anoreva zvakafanana 2-Methylbenzoyl Chloride
Nhamba yeCAS 933-88-0
Nhamba yeCAT RF-PI396
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C8H7ClO
Molecular Weight 154.59
Melting Point 159.5-160.9℃
Boiling Point 88.0~90.0℃/12 mmHg (lit.)
Density 1.185 g/mL pa25℃ (lit.)
Refractive Index n20/D 1.5549(lit.)
Mvura Solubility Inopindirana neMvura
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Colorless Clear Liquid
Assay ≥99.0%
Benzoyl Chloride ≤0.30%
M&P-Methyl Benzoyl Chloride ≤0.50%
O-Toluic Acid ≤0.50%
Kumwe Kusachena Kusingataurwi ≤0.20%
Zvose Zvisina Kuchena ≤1.0%
Kurasika paKuomesa ≤0.50%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Package & Kuchengeta:

Package: Bhodhoro, 25kg / Barrel kana 180kg Plastic dhiramu, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

1

FAQ:

Application:

o-Toluoyl Chloride (CAS 933-88-0) inoshandiswa semushonga wepakati.o-Toluoyl Chloride inoshandiswa mukugadzira kana quinolinone isanganiswa seSARS CoV 3CLpro inhibitors.Inoshandiswawo mukugadzirwa kwebenzooxaboroles semuromo unoshanda anti-inflammatory agents.o-Toluoyl Chloride ndiyo yepakati yeTolvaptan (CAS 150683-30-0) yekurapa hyponatremia.Tolvaptan, inozivikanwawo seOPC-41061, inosarudza, inokwikwidza arginine vasopressin receptor 2 antagonist inoshandiswa kurapa hyponatremia (low blood sodium levels) inobatanidza ne congestive heart failure, cirrhosis, uye syndrome ye inappropriate antidiuretic hormone (SIADH).Otsuka Pharmaceutical ine rezinesi tolvaptan pasi pezita rekutengesa Samsca mushure mekunge FDA yabvumidza mushonga uyu muna Chivabvu 2009.

Nyora meseji yako pano ugotitumira